You won't find any mention of XMRV in the new large, randomized trial comparing adaptive pacing, cognitive behavior, and graded exercise therapy to specialist medical care for chronic fatigue syndrome (CFS). The study was published today in The Lancet, whose editors last September opined that CFS is not "a physical disease" but, rather, a "heterogeneous family of disorders, and it seems most likely that these disorders arise from a constellation of pathophysiological causes."
The publication is causing quite a stir in the ME/CFS community. Start with the Readers' Comments to the New York Times coverage. Next search #mecfs and #xmrv on Twitter if you've got a deeper interest and a few hours to spare. Then see our previous posts on CFS and the XMRV retrovirus. Still, our Chronic Fatigue Syndrome page on HyperbaricLink shows nothing but scant evidence that hyperbaric oxygen is at all effective.
[Photo: Robert Bukaty/AP]
O2.0 is the news blog of HyperbaricLink, the independent web guide to hyperbaric oxygen therapy.